Sign In
Buy CASI
$0.208
+0 (+0%)
At Close: May 22, 2026
CASI Pharmaceuticals, Inc. To Participate In Jefferies Virtual Healthcare Conference
07:00am, Thursday, 27'th May 2021
ROCKVILLE, Md. and BEIJING, May 27, 2021 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics
Oppenheimer Has 5 Sizzling Biotech Stocks to Buy Now Trading Under $10
06:15am, Saturday, 22'nd May 2021
While most of Wall Street focuses on large-cap and mega-cap stocks, as they provide a degree of safety and liquidity, many investors are limited in the number of shares they can buy.
CASI Pharmaceuticals, Inc. (CASI) CEO Dr. Wei-Wu He on Q1 2021 Results - Earnings Call Transcript
04:56pm, Wednesday, 19'th May 2021
CASI Pharmaceuticals, Inc. (CASI) CEO Dr. Wei-Wu He on Q1 2021 Results - Earnings Call Transcript
CASI Pharmaceuticals To Report First Quarter 2021 Financial Results And Host Conference Call May 13, 2021
07:00am, Tuesday, 11'th May 2021
ROCKVILLE, Md. and BEIJING, May 11, 2021 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics
CASI Stock: $3.80 Target By Mizuho
11:08pm, Friday, 30'th Apr 2021
The shares of CASI Pharmaceuticals Inc (NASDAQ: CASI) have received a $3.80 price target by Mizuho. These are the details.
3 Hot Penny Stocks To Buy With Analysts Expecting Up To 383%
11:39am, Friday, 30'th Apr 2021
Penny stocks to buy according to top Wall Street analysts The post 3 Hot Penny Stocks To Buy With Analysts Expecting Up To 383% appeared first on Penny Stocks to Buy, Picks, News and Information | Pen
CASI Stock Price Increased Over 10% Pre-Market: Why It Happened
06:28am, Wednesday, 31'st Mar 2021
The stock price of CASI Pharmaceuticals, Inc. (Nasdaq: CASI) increased by over 10% pre-market. This is why it happened.
CASI Pharmaceuticals Announces Full Year 2020 Financial Results
07:00am, Tuesday, 30'th Mar 2021
ROCKVILLE, Md. and BEIJING, March 30, 2021 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeuti
Why CASI Pharmaceuticals Is Crashing Today
03:57pm, Wednesday, 24'th Mar 2021
Investors don't like that the company is hitting up the market for more cash.
CASI Pharmaceuticals Announces Pricing Of $32,500,000 Public Offering Of Common Stock
08:30am, Wednesday, 24'th Mar 2021
ROCKVILLE, Md. and BEIJING, March 24, 2021 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutic
CASI Pharmaceuticals Announces Proposed Public Offering Of Common Stock
04:01pm, Tuesday, 23'rd Mar 2021
ROCKVILLE, Md. and BEIJING, March 23, 2021 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics
CASI Pharmaceuticals To Host Business Update Call March 12, 2021
04:30pm, Thursday, 11'th Mar 2021
ROCKVILLE, Md. and BEIJING, March 11, 2021 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutic
CASI Pharmaceuticals To Develop CB-5339 In Cancer Indications In China
10:17am, Monday, 08'th Mar 2021
Cleave Therapeutics Inc has out-licensed CB-5339 to CASI Pharmaceuticals Inc (NASDAQ: CASI) in mainland China, Taiwan, Hong Kong, and Macau. Cleave and CASI will develop CB-5339 in both hematolo
CASI Pharmaceuticals Announces CNCT19 (CD19 CAR-T) Receives China Breakthrough Therapy Designation
07:00am, Wednesday, 23'rd Dec 2020
ROCKVILLE, Md., and BEIJING, Dec. 23, 2020 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics
CASI Pharmaceuticals Announces Partner Juventas Completes $65 Million Financing And Initiates Registration Study For CNCT19 (CD19 CAR-T)
09:00pm, Wednesday, 18'th Nov 2020
ROCKVILLE, Md. and BEIJING, Nov. 18, 2020 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics
